Related Experiment Video
Updated: Feb 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
The limitations of using randomised controlled trials as a basis for developing treatment guidelines
Roger Mulder1,2, Ajeet B Singh1,3, Amber Hamilton1,4,5,6
1Mood Assessment and Classification (MAC) Committee, Sydney, Australia.
Randomised controlled trials (RCTs) are crucial but have limitations. This perspective questions RCT assumptions, highlighting distortions that affect clinical decision-making and treatment guidelines.
Area of Science:
- Psychiatry
- Clinical Psychology
- Evidence-Based Medicine
Background:
- Randomised controlled trials (RCTs) are the benchmark for evaluating psychotropic medications and psychological interventions.
- Despite their importance, RCTs have limitations in reflecting real-world clinical practice and individual patient outcomes.
- Biases in design, recruitment, sampling, and analysis can further compromise the generalizability of RCT findings.
Purpose of the Study:
- To critically examine the inherent limitations and potential biases within the design and execution of RCTs.
- To highlight how these limitations and biases can distort findings, impacting their credibility and clinical utility.
- To advocate for improved standards in RCTs and the critical appraisal of evidence used in clinical guidelines.
Main Methods:
- This is a perspective piece, involving a critical analysis of existing literature and methodologies.
- It examines the assumptions underpinning RCTs and their application in developing clinical practice guidelines.
- The authors discuss the impact of real-world study limitations and the effectiveness of current corrective measures like trial registration and CONSORT.
Main Results:
- RCTs provide valuable efficacy data for specific samples but may not predict effectiveness in diverse clinical settings or individual patients.
- Despite implemented standards, many trials do not meet optimal criteria, yet their results influence clinical decision-making.
- Widespread distortion of findings from RCTs currently undermines the credibility of this research design.
Conclusions:
- Clinical guidelines should offer clearer advice on evaluating evidence quality and relevance for practice.
- External bodies should enhance monitoring of RCTs to ensure published outcomes accurately reflect real-world findings.
- A more nuanced approach to interpreting RCTs is necessary to maintain the integrity of evidence-based practice in mental health.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Clinical Trials
There are four phases in a clinical trial. A phase one...
Randomized Experiments
Simple randomization
Simple...
Clinical Trials: Overview
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
